Redcare Pharmacy N.V.
ISIN: NL0012044747
WKN: A2AR94
22 April 2026 09:15AM

EQS-News: Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.

Redcare Pharmacy N.V. · ISIN: NL0012044747 · EQS - Company News
Country: Netherlands · Primary market: Netherlands · EQS NID: 2311150

EQS-News: Redcare Pharmacy N.V. / Key word(s): Miscellaneous
Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.

22.04.2026 / 09:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


Redcare Pharmacy becomes the first pharmacy to use new TI access technology for faster e-prescription processes.

Sevenum, Netherlands, April 22, 2026. Redcare Pharmacy’s B2B access to the telematics infrastructure (TI) is now significantly improved through the use of a new technology and identity solution from partners ehex and D-Trust (Bundesdruckerei). The previously required physical institutional card is being replaced by a fully digital identity of the pharmacy within the TI gateway. This is also noticeable for customers via their B2C access: access to e-prescriptions via CardLink remains unchanged in terms of process but becomes faster overall and reduces waiting times.

The transition to the so-called HSM-B technology marks a technological advancement in the ongoing development of the telematics infrastructure. It significantly improves speed, stability and scalability of the connection, while also enabling a more efficient cost structure. This creates an important foundation for further growth in the e-prescription segment.

Customers benefit from measurable improvements in the e-prescription process: after the CardLink step, prescriptions can be retrieved and processed more quickly from the gematik server. This reduces waiting times in the Rx ordering process and noticeably improves performance when redeeming e-prescriptions.

The new solution is part of the next expansion stage of the TI architecture within the framework of gematik TI 2.0. It addresses increasing demands for speed and scalability in the digital healthcare market. The rollout begins with a test phase together with ehex as well as additional partners and will serve as the basis for a subsequent broader rollout.

Lode Fastré, CIO of Redcare Pharmacy: “The introduction of this technology is an important step in further scaling our e-prescription business. It improves the performance of our systems and lays the foundation for future growth. At the same time, it underlines our leading role in connecting to the TI infrastructure.”

___

About Redcare Pharmacy.

Originally founded in 2001, Redcare Pharmacy N.V. (formerly known as Shop Apotheke Europe N.V.) today is the leading e-pharmacy in Europe, currently active in seven countries: Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland.

Headquartered in Sevenum, close to the Dutch city of Venlo and in the heart of Europe, the company has locations in Cologne, Berlin, Munich, Tongeren, Warsaw, Pilsen, Settala (Milan), Lille and Eindhoven.

As the one-stop pharmacy of the future, Redcare Pharmacy offers over 14.2 million active customers a wide range of more than 250,000 products at attractive and fair prices. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands.

 

Pharmaceutical safety is of top priority. Being a pharmacy at its core, Redcare stands for comprehensive pharmaceutical consultation service. Since care is at the heart of everything Redcare does, the company provides services for all stages of life and health. This ranges from its marketplaces to unique delivery options and medication management.

Redcare Pharmacy N.V. has been listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) since 2016. As of 19 June 2023, the company is a member of the MDAX selection index.



22.04.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Redcare Pharmacy N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: investors@redcare-pharmacy.com
Internet: www.redcare-pharmacy.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y072
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
EQS News ID: 2311150

 
End of News EQS News Service

2311150  22.04.2026 CET/CEST

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2020 2021 2022 2023 2024 2025 2026e
Sales1 968,06 1.060,32 1.204,35 1.798,76 2.370,58 2.940,90 3.353,00
EBITDA1,2 15,20 -38,73 -29,66 39,99 29,23 47,40 77,00
EBITDA-Margin3 1,57 -3,65 -2,46 2,22 1,23 1,61 2,30
EBIT1,4 -0,87 -65,70 -69,17 -17,30 -38,99 -28,50 9,00
EBIT-Margin5 -0,09 -6,20 -5,74 -0,96 -1,65 -0,97 0,27
Net Profit (Loss)1 -16,77 -74,19 -77,65 -11,61 -46,36 -39,40 -15,00
Net-Margin6 -1,73 -7,00 -6,45 -0,65 -1,96 -1,34 -0,45
Cashflow1,7 17,80 11,64 -29,11 61,46 22,13 31,00 39,00
Earnings per share8 -1,17 -4,15 -4,32 -0,73 -2,27 -1,87 -0,73
Dividend per share8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: Forvis Mazars

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Redcare Pharmacy
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A2AR94 NL0012044747 N.V. 1.058,76 Mio € 13.10.2016 Halten 9F3893WC+F5
* * *
PE 2027e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
31,18 0,00 0,00 -27,46 2,31 34,15 0,36
Dividends
Dividend '2023
in €
Dividend '2024
in €
Dividend '2025e
in €
Div.-Yield '2025e
in %
0,00 0,00 0,00 0,00%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
15.04.2026 06.05.2026 29.07.2026 29.10.2026 04.03.2026
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+3,11%
51,45 €
ATH 249,00 €
+1,50% -26,65% -21,87% -58,84% +83,75%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2026          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2026 by Gereon Kruse #BGFL